Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vaccines for prevention of meningococcal disease.

× No keyword cloud information.

31 in total

1. Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.

Authors: E C Beuvery; F Miedema; R van Delft; J Haverkamp
Journal: Infect Immun Date: 1983-04 Impact factor: 3.441

2. Five structural classes of major outer membrane proteins in Neisseria meningitidis.

Authors: C M Tsai; C E Frasch; L F Mocca
Journal: J Bacteriol Date: 1981-04 Impact factor: 3.490

3. Physicochemical and immunological characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods.

Authors: E C Beuvery; A vd Kaaden; V Kanhai; A B Leussink
Journal: Vaccine Date: 1983-12 Impact factor: 3.641

4. Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins.

Authors: R E Mandrell; W D Zollinger
Journal: J Immunol Methods Date: 1984-02-24 Impact factor: 2.303

Review 5. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors: S C Ross; P Densen
Journal: Medicine (Baltimore) Date: 1984-09 Impact factor: 1.889

6. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.

Authors: H J Jennings; C Lugowski
Journal: J Immunol Date: 1981-09 Impact factor: 5.422

7. Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development.

Authors: K Saukkonen; H Abdillahi; J T Poolman; M Leinonen
Journal: Microb Pathog Date: 1987-10 Impact factor: 3.738

8. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.

Authors: H Käyhty; V Karanko; H Peltola; S Sarna; P H Mäkelä
Journal: J Infect Dis Date: 1980-12 Impact factor: 5.226

9. Impairment of the immune response to vaccination after acute malaria.

Authors: W A Williamson; B M Greenwood
Journal: Lancet Date: 1978-06-24 Impact factor: 79.321

10. Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide.

Authors: C Moreno; M R Lifely; J Esdaile
Journal: Infect Immun Date: 1985-02 Impact factor: 3.441

40 in total

1. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.

Authors: E R van der Voort; P van der Ley; J van der Biezen; S George; O Tunnela; H van Dijken; B Kuipers; J Poolman
Journal: Infect Immun Date: 1996-07 Impact factor: 3.441

2. Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein.

Authors: N Cadieux; M Plante; C R Rioux; J Hamel; B R Brodeur; D Martin
Journal: Infect Immun Date: 1999-09 Impact factor: 3.441

10. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.

Authors: F H Azmi; A H Lucas; H V Raff; D M Granoff
Journal: Infect Immun Date: 1994-05 Impact factor: 3.441

Vaccines for prevention of meningococcal disease.

1. Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.

2. Five structural classes of major outer membrane proteins in Neisseria meningitidis.

3. Physicochemical and immunological characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods.

4. Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins.

Review 5. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

6. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.

7. Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development.

8. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.

9. Impairment of the immune response to vaccination after acute malaria.

10. Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide.

1. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.

2. Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein.

3. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.

4. Molecular epidemiology of recent belgian isolates of Neisseria meningitidis serogroup B.

5. Primary care provision of specialist services.

6. Telemedicine: 'communication' by any other name?

7. Keeping the meningococcus out of the media.

Review 8. Update on meningococcal disease with emphasis on pathogenesis and clinical management.

9. Phylogenetic and epidemiological analysis of Neisseria meningitidis using DNA probes.

10. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.